Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve P Watson

Showing results (121-130 of 270) with videos related to

Pageof 27
Sort By:
Blood|December 20, 2003
GPIb-dependent platelet activation is dependent on Src kinases but not MAP kinase or cGMP-dependent kinaseStuart J Marshall, Yotis A Senis, Jocelyn M Auger, et al.
The Journal of Biological Chemistry|November 25, 2010
Syk-dependent phosphorylation of CLEC-2: a novel mechanism of hem-immunoreceptor tyrosine-based activation motif signalingSonia Séverin, Alice Y Pollitt, Leyre Navarro-Nuñez, et al.
Nature Communications|December 23, 2017
The podoplanin-CLEC-2 axis inhibits inflammation in sepsisJulie Rayes, Siân Lax, Surasak Wichaiyo, et al.
Blood|September 25, 2012
Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panelBan B Dawood, Gillian C Lowe, Marie Lordkipanidzé, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 18, 2006
GPVI potentiation of platelet activation by thrombin and adhesion molecules independent of Src kinases and SykSascha C Hughan, Craig E Hughes, Owen J T McCarty, et al.
Blood|August 10, 2021
Antiplatelet drugs block platelet activation by VITT patient serumChristopher W Smith, Samantha J Montague, Caroline Kardeby, et al.
The Biochemical Journal|December 6, 2003
Glycoproteins VI and Ib-IX-V stimulate tyrosine phosphorylation of tyrosine kinase Syk and phospholipase Cgamma2 at distinct sitesKatsue Suzuki-Inoue, Jonathan I Wilde, Robert K Andrews, et al.
Bioorganic & Medicinal Chemistry Letters|June 30, 2009
Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part one: lead identificationIan P Holmes, Fabrizio Micheli, Simon Gaines, et al.
International Journal of Molecular Sciences|January 11, 2022
Role of Tyrosine Kinase Syk in Thrombus Stabilisation at High ShearGina Perrella, Samantha J Montague, Helena C Brown, et al.
Therapeutic Advances in Hematology|May 17, 2021
Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinibNichola Cooper, Ivy Altomare, Mark R Thomas, et al.
Pageof 27

Showing results (121-130 of 270) with videos related to

Sort By:
Pageof 27
Blood|December 20, 2003
GPIb-dependent platelet activation is dependent on Src kinases but not MAP kinase or cGMP-dependent kinaseStuart J Marshall, Yotis A Senis, Jocelyn M Auger, et al.
The Journal of Biological Chemistry|November 25, 2010
Syk-dependent phosphorylation of CLEC-2: a novel mechanism of hem-immunoreceptor tyrosine-based activation motif signalingSonia Séverin, Alice Y Pollitt, Leyre Navarro-Nuñez, et al.
Nature Communications|December 23, 2017
The podoplanin-CLEC-2 axis inhibits inflammation in sepsisJulie Rayes, Siân Lax, Surasak Wichaiyo, et al.
Blood|September 25, 2012
Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panelBan B Dawood, Gillian C Lowe, Marie Lordkipanidzé, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 18, 2006
GPVI potentiation of platelet activation by thrombin and adhesion molecules independent of Src kinases and SykSascha C Hughan, Craig E Hughes, Owen J T McCarty, et al.
Blood|August 10, 2021
Antiplatelet drugs block platelet activation by VITT patient serumChristopher W Smith, Samantha J Montague, Caroline Kardeby, et al.
The Biochemical Journal|December 6, 2003
Glycoproteins VI and Ib-IX-V stimulate tyrosine phosphorylation of tyrosine kinase Syk and phospholipase Cgamma2 at distinct sitesKatsue Suzuki-Inoue, Jonathan I Wilde, Robert K Andrews, et al.
Bioorganic & Medicinal Chemistry Letters|June 30, 2009
Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part one: lead identificationIan P Holmes, Fabrizio Micheli, Simon Gaines, et al.
International Journal of Molecular Sciences|January 11, 2022
Role of Tyrosine Kinase Syk in Thrombus Stabilisation at High ShearGina Perrella, Samantha J Montague, Helena C Brown, et al.
Therapeutic Advances in Hematology|May 17, 2021
Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinibNichola Cooper, Ivy Altomare, Mark R Thomas, et al.
Pageof 27